UCLA Vatche & Tamar Manoukian Division of Digestive Diseases

We’re proud to share that UCLA GI & GI Surgery has once again been ranked among the top programs in the country—earning the #8 spot nationally in the 2025-2026 U.S. News & World Report Best Hospitals survey. This distinction also makes us the highest-ranked public university hospital for GI and GI surgery in the United States.

Established in 1953, the Vatche & Tamar Manoukian Division of Digestive Diseases has been a world leader in the diagnosis, treatment, and research aimed at combating debilitating and deadly disorders affecting the gastrointestinal tract. Its outstanding clinical, research, and training programs engage in creative and innovative approaches to today's gastrointestinal (GI) disorders. Rooted in quality patient care with an academic mindset, our philosophy is strengthened by the technological advances and unsurpassed resources available to us as part of the broader UCLA Health System, including the David Geffen School of Medicine at UCLA, Ronald Reagan UCLA Medical Center and UCLA Santa Monica Medical Center.


Gastro

For patients and visitors

In addition to being at the forefront of research and training, our physicians offer the highest-quality patient care. They see patients at Ronald Reagan UCLA Medical Center in Westwood, UCLA Santa Monica Medical Center, and at UCLA community clinics across Southern California.

Fellowship Program

The UCLA GI Fellowship Program produces experts in every facet of clinical gastroenterology, hepatology, and related research. It is among the largest program of its kind in the nation, with 23 fellows receiving training at any time.

Fellowship Program participants outside
Scientist examining in front of a microscope

Research

Research has been a mainstay of our division since it was established in 1953, and we have grown to become a world leader in contributing new digestive diseases-related knowledge through scientific studies. Our faculty publish extensively and play prominent roles in national meetings, advancing the state of the science and ushering in cutting-edge treatments that improve and save lives.

Latest news